胸腺噴丁

胸腺噴丁
臨床資料
其他名稱	(3S)-3-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid
ATC碼	L03AX09 (WHO) ;
識別資訊
	IUPAC命名法 L-arginyl-L-lysyl-L-α-aspartyl-L-valyl-L-tyrosine; ;
CAS號	69558-55-0
PubChem CID	451417;
ChemSpider	397640 ;
UNII	O3Y80ZF13F;
KEGG	D06117 ;
ChEMBL	ChEMBL156025 ;
NIAID ChemDB	000127;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID9046609 ;
ECHA InfoCard	100.242.320
化學資訊
化學式	C30H49N9O9
摩爾質量	679.78 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES O=C(N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(O)cc1)C(C)C)CC(=O)O)CCCCN)[C@@H](N)CCC/N=C(\N)N;
	InChI InChI=1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24-/m0/s1 ; Key:PSWFFKRAVBDQEG-YGQNSOCVSA-N ;

胸腺噴丁（英語：Thymopentin，別名胸腺五肽）是一種胸腺肽^[1]，具有免疫刺激（英語：immunostimulant）作用（作用於T細胞^[2]），因此曾在1983-1985年間用於一些對於艾滋病的臨床研究中。在針對少數病人進行的短期對應治療中，胸腺噴丁有助於提升免疫狀態。^[3]^[4]^[5]

參考資料

^ Peng Y, Chen Z, Yu W, et al. Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells. Cell Biology International. July 2008, 32 (10): 1265–71. PMID 18692582. S2CID 24144448. doi:10.1016/j.cellbi.2008.07.011.
^ Liu Z, Zheng X, Wang J, Wang E. Egli M , 編. Molecular analysis of thymopentin binding to HLA-DR molecules. PLOS ONE. 2007, 2 (12): e1348. Bibcode:2007PLoSO...2.1348L. PMC 2137936 . PMID 18159232. doi:10.1371/journal.pone.0001348.
^ Mascart-Lemone F, Huygen K, Clumeck N, Brenez D, Bolla K, Duchateau J. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients. Lancet. 1983, 322 (8352): 735–736. PMID 6193382. S2CID 519367. doi:10.1016/S0140-6736(83)92271-7.
^ Clumeck N, Van de Perre P, Mascart-Lemone F, Cran S, Bolla K, Duchateau J. Preliminary results on clinical and immunological effects of thymopentin in AIDS. Int J Clin Pharmacol Res. 1984, 4 (6): 459–463. PMID 6398315.
^ Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K. Thymopentin treatment in AIDS and pre-AIDS patients. Surv Immunol Res. 1985, 4 (1): supp1 58–62 [2021-04-20]. PMID 3898293. doi:10.1007/BF02919057 (不活躍 2021-01-14). （原始內容存檔於2021-04-27）.

[pmid18692582-1] Peng Y, Chen Z, Yu W, et al. Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells. Cell Biology International. July 2008, 32 (10): 1265–71. PMID 18692582. S2CID 24144448. doi:10.1016/j.cellbi.2008.07.011.

[pmid18159232-2] Liu Z, Zheng X, Wang J, Wang E. Egli M , 編. Molecular analysis of thymopentin binding to HLA-DR molecules. PLOS ONE. 2007, 2 (12): e1348. Bibcode:2007PLoSO...2.1348L. PMC 2137936 . PMID 18159232. doi:10.1371/journal.pone.0001348.

[pmid6193382-3] Mascart-Lemone F, Huygen K, Clumeck N, Brenez D, Bolla K, Duchateau J. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients. Lancet. 1983, 322 (8352): 735–736. PMID 6193382. S2CID 519367. doi:10.1016/S0140-6736(83)92271-7.

[pmid6398315-4] Clumeck N, Van de Perre P, Mascart-Lemone F, Cran S, Bolla K, Duchateau J. Preliminary results on clinical and immunological effects of thymopentin in AIDS. Int J Clin Pharmacol Res. 1984, 4 (6): 459–463. PMID 6398315.

[pmid3898293-5] Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K. Thymopentin treatment in AIDS and pre-AIDS patients. Surv Immunol Res. 1985, 4 (1): supp1 58–62 [2021-04-20]. PMID 3898293. doi:10.1007/BF02919057 (不活躍 2021-01-14). （原始內容存檔於2021-04-27）.

[1]

[2]

[3]

[4]

[5]